M Capalbo

604 total citations
12 papers, 493 citations indexed

About

M Capalbo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, M Capalbo has authored 12 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in M Capalbo's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). M Capalbo is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). M Capalbo collaborates with scholars based in Italy and United States. M Capalbo's co-authors include Ferruccio Bonino, Maurizia Rossana Brunetto, Filippo Oliveri, G Verme, Domenico Criscuolo, Ezio David, Elisabetta Chiaberge, Giuseppe Rocca, Giorgio Maria Saracco and Maria Lorena Abate and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

M Capalbo

12 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Capalbo Italy 7 439 427 67 20 20 12 493
Uta Naumann Germany 12 578 1.3× 575 1.3× 70 1.0× 36 1.8× 30 1.5× 32 680
Floriano Rosina Italy 9 669 1.5× 652 1.5× 90 1.3× 22 1.1× 47 2.4× 13 720
J. Petersen Germany 9 414 0.9× 396 0.9× 51 0.8× 21 1.1× 18 0.9× 33 470
T. Santantonio Italy 8 656 1.5× 677 1.6× 74 1.1× 11 0.6× 22 1.1× 17 709
Michèle Martinot France 9 418 1.0× 419 1.0× 57 0.9× 13 0.7× 9 0.5× 15 461
Marie Matsuda Japan 15 776 1.8× 808 1.9× 108 1.6× 19 0.9× 26 1.3× 28 836
Cecilia Marrocco Italy 11 454 1.0× 466 1.1× 65 1.0× 9 0.5× 11 0.6× 15 500
Francesco Torre Italy 11 263 0.6× 251 0.6× 28 0.4× 19 0.9× 48 2.4× 21 347
Y. Lazizi France 10 186 0.4× 199 0.5× 45 0.7× 16 0.8× 30 1.5× 13 262
K. Gmelin Germany 11 262 0.6× 231 0.5× 51 0.8× 31 1.6× 21 1.1× 36 323

Countries citing papers authored by M Capalbo

Since Specialization
Citations

This map shows the geographic impact of M Capalbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Capalbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Capalbo more than expected).

Fields of papers citing papers by M Capalbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Capalbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Capalbo. The network helps show where M Capalbo may publish in the future.

Co-authorship network of co-authors of M Capalbo

This figure shows the co-authorship network connecting the top 25 collaborators of M Capalbo. A scholar is included among the top collaborators of M Capalbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Capalbo. M Capalbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Stocchi, Laura, Emanuela Polidori, Lucia Potenza, et al.. (2015). Mutational analysis of mitochondrial DNA in Brugada syndrome. Cardiovascular Pathology. 25(1). 47–54. 14 indexed citations
3.
Colombatto, P., Filippo Oliveri, Gioacchino Leandro, et al.. (1997). Platelet and white blood cell counts during therapy with different types of alpha interferon in patients with chronic viral hepatitis. Investigators of the Alpha Interferon Study Group of Piemonte, Italy.. PubMed. 29(5). 441–7. 13 indexed citations
4.
Brunetto, Maurizia Rossana, et al.. (1995). Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha.. PubMed. 22(1 Suppl). 42–4. 37 indexed citations
5.
Capalbo, M, et al.. (1994). Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.. PubMed. 26(5). 238–41. 5 indexed citations
6.
Brunetto, Maurizia Rossana, M. Giarin, Giorgio Maria Saracco, et al.. (1993). Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology. 105(3). 845–850. 159 indexed citations
7.
Abendroth, D., et al.. (1992). Pancreatic graft outcome after combined whole pancreas and liver retrieval. PubMed. 24(3). 821–821. 2 indexed citations
8.
Capalbo, M, et al.. (1992). Treatment of chronic hepatitis B with beta interferon given intramuscularly: a pilot study.. PubMed. 24(4). 203–5. 1 indexed citations
9.
Brunetto, Maurizia Rossana, Filippo Oliveri, Giuseppe Rocca, et al.. (1989). Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology. 10(2). 198–202. 193 indexed citations
10.
Brunetto, Maurizia Rossana, Filippo Oliveri, Antonio Baldi, et al.. (1989). Hepatocellular carcinoma and hepatitis delta virus infection. Journal of Hepatology. 9. S123–S123. 2 indexed citations
11.
Brunetto, Maurizia Rossana, Domenico Criscuolo, M. Baldi, et al.. (1988). Treatment of chronic type B hepatitis, positive for the antibody to hepatitis B "e" antigen with alpha-2A-interferon.. PubMed. 139(2). 130–1. 2 indexed citations
12.
Bonino, Ferruccio, Francesco Negro, M. Baldi, et al.. (1987). The natural history of chronic delta hepatitis.. PubMed. 234. 145–52. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026